ln recent years, we and others have determined that at least one endothelial process, in addition to NO and cyclooxygenase metabolites, dilates cerebral vessels. This new process, termed """"""""endothelium-derived hyperpolarizing factor"""""""" or EDHF, is likely an important dilator mechanism in the cerebral circulation during normal physiological states and following pathological conditions. In the proposed studies, we will address the mechanism of EDHF in cerebral arteries. The major hypothesis to be tested is that tandem-pore domain potassium channels are involved with the EDHF-mediated dilations in cerebral vessels of the rat. In order for the above hypothesis to be valid then all of the following specific aims must be true. (Specific Aim 1) Tandem-pore domain potassium channels must be present in cerebral arteries;(Specific Aim 2) activation of tandem-pore domain potassium channels must elicit dilation in cerebral arteries, and (Specific Aim 3) inhibition of tandem-pore domain potassium channels must inhibit EDHF-mediated dilations.
In Specific Aim 1, we plan to use a combination of RT-PCR, Western analysis, immunohistochemistry, and electrophysiology to demonstrate the presence of the tandem pore domain potassium channels in cerebral arteries and, further, demonstrate that they are functional.
In specific Aim 2, we will use isolated perfused cerebral arteries to determine if activation of these channels produces dilation. Furthermore, we plan to determine if inhibition of channel expression (anti-sense) and inhibition by pharmacological blockers antagonizes dilations produced by these potassium channels.
In Specific Aim 3, we propose to determine if inhibition of tandem pore domain potassium channels inhibit EDHF-mediated dilations. Completion of the proposed studies will provide important insight into EDHF and its mechanism of circulatory control in brain. Furthermore, we anticipate that new information regarding tandem pore domain potassium channels will be a big step in the understanding of cerebral circulatory control.
| Madry, Christian; Kyrargyri, Vasiliki; Arancibia-Cárcamo, I Lorena et al. (2018) Microglial Ramification, Surveillance, and Interleukin-1? Release Are Regulated by the Two-Pore Domain K+ Channel THIK-1. Neuron 97:299-312.e6 |
| Schwingshackl, Andreas; Teng, Bin; Makena, Patrudu et al. (2014) Deficiency of the two-pore-domain potassium channel TREK-1 promotes hyperoxia-induced lung injury. Crit Care Med 42:e692-701 |
| Nielsen, Gorm; Wandall-Frostholm, Christine; Sadda, Veeranjaneyulu et al. (2013) Alterations of N-3 polyunsaturated fatty acid-activated K2P channels in hypoxia-induced pulmonary hypertension. Basic Clin Pharmacol Toxicol 113:250-8 |
| Ford, Kevin J; Arroyo, David A; Kay, Jeremy N et al. (2013) A role for TREK1 in generating the slow afterhyperpolarization in developing starburst amacrine cells. J Neurophysiol 109:2250-9 |
| Lloyd, Eric E; Crossland, Randy F; Phillips, Sharon C et al. (2011) Disruption of K(2P)6.1 produces vascular dysfunction and hypertension in mice. Hypertension 58:672-8 |
| Namiranian, Khodadad; Brink, Christa D; Goodman, Jerry Clay et al. (2011) Traumatic brain injury in mice lacking the K channel, TREK-1. J Cereb Blood Flow Metab 31:e1-6 |
| Namiranian, Khodadad; Lloyd, Eric E; Crossland, Randy F et al. (2010) Cerebrovascular responses in mice deficient in the potassium channel, TREK-1. Am J Physiol Regul Integr Comp Physiol 299:R461-9 |
| Parelkar, Nikhil K; Silswal, Neerupma; Jansen, Kirsten et al. (2010) 2,2,2-trichloroethanol activates a nonclassical potassium channel in cerebrovascular smooth muscle and dilates the middle cerebral artery. J Pharmacol Exp Ther 332:803-10 |
| Lloyd, Eric E; Marrelli, Sean P; Bryan Jr, Robert M (2009) cGMP does not activate two-pore domain K+ channels in cerebrovascular smooth muscle. Am J Physiol Heart Circ Physiol 296:H1774-80 |
| Lloyd, Eric E; Marrelli, Sean P; Namiranian, Khodadad et al. (2009) Characterization of TWIK-2, a two-pore domain K+ channel, cloned from the rat middle cerebral artery. Exp Biol Med (Maywood) 234:1493-502 |
Showing the most recent 10 out of 16 publications
